Rituxan (rituximab) is a biologic DMARD used to treat adults with moderately to severely active rheumatoid arthritis (RA) who have had an inadequate response to TNF antagonist therapies. Here are some key points about Rituxan:

- Mechanism: Rituxan works by inhibiting B-lymphocyte cells, preventing them from attacking Show Full Answer

Rituxan (rituximab) is a biologic DMARD used to treat adults with moderately to severely active rheumatoid arthritis (RA) who have had an inadequate response to TNF antagonist therapies. Here are some key points about Rituxan:

- Mechanism: Rituxan works by inhibiting B-lymphocyte cells, preventing them from attacking connective tissues.
- Administration: It is given as two intravenous infusions, 15 days apart. Each infusion takes between two to four hours.
- Effectiveness: It begins taking effect about six weeks after the second infusion, with effects lasting up to six months.
- Side Effects: Common side effects include infusion reactions, fever, chills, low white blood cell counts, and infections. Rare but serious side effects include severe infections, heart problems, and a serious brain infection called progressive multifocal leukoencephalopathy (PML).

For more personal experiences, consider joining myRAteam, a social network for people with RA, where members share their stories and advice.

 This AI-generated response comes from myRAteam and other selected sources. It is not a substitute for medical advice. Always ask your doctor about specific health concerns.

Rituxan (Rituximab) for Rheumatoid Arthritis | myRAteam

Infusion Therapy for Rheumatoid Arthritis: Your Guide | myRAteam